Advanced Research Technologies

ART is in the process of bringing to market SoftScan�, a digital imaging device which uses the Company's time resolved imaging technology (also known as time domain technology) to detect and diagnose breast cancer. This product represents a new imaging solution for the detection of breast cancer without the adverse consequences associated with traditional technology. ART believes that SoftScan� also offers a solution to issues relating to quality of care and treatment costs that the medical sector is facing. In order to gain rapid entry into the market for breast cancer screening and diagnostic devices, SoftScan� is initially being introduced as a diagnostic device able to complement other screening and diagnostic technologies, such as digital X-ray. The Company's imaging technologies are also capable of being applied in other industry sectors. ART has identified and is pursuing applications in sectors where the potential exists for the Company to grow profitably. For example, the Company has started the commercialization of ISIS�, a product that uses ART's thermal imaging technology in order to detect defects in printed circuit boards (PCBs) that are assembled using surface mount technology (SMT), an advanced manufacturing technology used to attach electronic components onto the surface of PCBs.